Incidence of Ssi After c.s

March 12, 2026 updated by: mona magdy helmy, Assiut University

Incidence of Surgical Site Infection After Cesarean Section and Compliance With Surgical Site Infection Prevention Stratigies .

aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Cesarean Section is one of the most commonly performed obstetric surgical procedures worldwide. Despite its importance in reducing maternal and fetal complications, it is associated with several postoperative complications, the most important of which is Surgical Site Infection. Surgical site infection after cesarean section can lead to increased maternal morbidity, prolonged hospital stay, and higher healthcare costs. Therefore, evaluating the incidence of surgical site infection and assessing adherence to preventive measures are essential for improving the quality of obstetric care. This study aims to determine the incidence of surgical site infection after cesarean section and to assess compliance with infection prevention strategies.

Study Type

Observational

Enrollment (Estimated)

105

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Asyut, Egypt
        • El Mabarra Health Insurance Hospital.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

The study population will include all women undergoing Cesarean Section at El-Mabarra Health Insurance Hospital during the study period. Eligible participants will be followed for 30 days after delivery to detect the occurrence of Surgical Site Infection. Women who meet the inclusion criteria and agree to participate in the study will be enrolled consecutively until the required sample size is reached.

Description

Inclusion Criteria:

  • All women who underwent cesarean section during the study period

Exclusion Criteria:

  • Patients who are lost to follow-up before completion of the 30-day postoperative assessment.

Patients with immunocompromised conditions, such as:

Chronic corticosteroid therapy. Immunosuppressive treatment. Known HIV infection with severe immunosuppression .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of surgical site infection after cesarean section
Time Frame: Baseline
superficial or deep surgical site infection
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Naeem A, et al. Incidence of surgical site infection after cesarean section. 2025.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

March 12, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ssi after c.s

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Site Infection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe